文献速递泌尿男性生殖肿瘤

局限性前列腺癌风险分层优化

Optimization of Risk Stratification in Localized Prostate Cancer.
PubMed 文献 · J Clin Oncol · 2018-01-05

本文为肿瘤学大查房系列文章,以一例67岁男性cT2b中危局限性前列腺癌病例为引,讨论诊断与治疗挑战并综述相关文献。文章旨在帮助读者将关键研究结果应用于临床实践。

要点

  • 病例为67岁男性,PSA 11 ng/mL,直肠指检右侧结节,活检示Gleason 3+4=7(分级分组2,30% Gleason 4成分),累及2针(60%与20%)。
  • 骨扫描与盆腔CT未见转移证据,按NCCN风险分组诊断为cT2b中危局限性前列腺癌。
  • 文章讨论是否应行前列腺磁共振成像,并综述多学科门诊中管理选项的选择。

核心结论

  • 本文通过病例展示与文献综述,讨论局限性前列腺癌风险分层的优化及管理选择。

研究设计与样本

  • 肿瘤学大查房系列文章,包含病例展示、诊断与管理挑战描述、相关文献综述及作者建议的管理方法总结。

主要发现

  • 病例为67岁男性,筛查发现PSA 11 ng/mL,直肠指检右侧结节,活检示前列腺腺癌Gleason 3+4=7(分级分组2,30% Gleason 4成分),累及2针(60%与20%)。
  • 骨扫描与盆腔CT阴性,按NCCN风险分组诊断为cT2b中危局限性前列腺癌。
  • 文章提出是否应行前列腺磁共振成像的问题,并指出该检查目前较为常见。

临床怎么用

  • 文章旨在帮助读者将关键研究结果应用于临床实践,包括多学科门诊中讨论管理选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 67-year-old retired engineering professor was found to have a prostate-specific antigen (PSA) level of 11 ng/mL on a screening test at his annual physical examination. A digital rectal examination revealed a nodule on the right side. He underwent a transrectal ultrasound-guided prostate biopsy that was notable for prostate adenocarcinoma, Gleason 3 + 4 = 7 (Gleason grade group 2; 30% Gleason 4 component) involving two cores (60% and 20% core involvement). A bone scan and pelvic computed tomography scan were negative for evidence of metastatic disease. (Should he undergo prostate magnetic resonance imaging? That seems rather common these days.) He was diagnosed with cT2b intermediate-risk localized prostate cancer (PCa) by National Comprehensive Cancer Network (NCCN) risk group and was seen in the multidisciplinary clinic to discuss management options (Table 1).

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Morgans AK. Optimization of Risk Stratification in Localized Prostate Cancer. J Clin Oncol. 2018. PMID: 29303624. doi:10.1200/JCO.2017.76.2971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。